CuraGen Company Profile

04:17 EDT 23rd September 2014 | BioPortfolio

CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company dedicated to improving the lives of patients by developing novel pharmaceutical products that address unmet medical needs. CuraGen’s deep understanding of the human genome has enabled us to gain greater insight into the molecular basis of disease. The Company's therapeutics are based on novel drug targets that are believed to play a role in proven mechanisms underlying disease. CuraGen has translated this understanding into a pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes. The Company’s strategy remains focused on advancing its pipeline of promising therapeutics through clinical and preclinical development. History CuraGen was founded when the massive undertaking to sequence the human genome was just beginning. The Company's strategy was based on discovering novel ways to combat disease through an understanding of how genes and their resulting proteins function within the human genome. CuraGen developed an integrated genomics, proteomics, and bioinformatics technology platform that was used to analyze the human genome, disease models, and therapeutic candidates. This approach led to the identification of disease-related genes and therapeutic targets with the subsequent development of novel pharmaceutical products. Today, CuraGen remains one of the leading genomics-based pharmaceutical companies in the industry with a pipeline of protein, antibody, and small molecule therapeutics. The Company is headquartered in Branford, CT.

Location

322 East Main Street
Branford
CT
06405
United States of America

Contact

Phone: (888) 436-6642 or (203) 481-1104
Fax: (203) 483-2552
Email: info@curagen.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company dedicated to improving the lives of patients by developing novel pharmaceutical products that address unmet medical needs. CuraGen’...

CuraGen Corporation

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing ...

More Information about "CuraGen" on BioPortfolio

We have published hundreds of CuraGen news stories on BioPortfolio along with dozens of CuraGen Clinical Trials and PubMed Articles about CuraGen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CuraGen Companies in our database. You can also find out about relevant CuraGen Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Bioinformatics
Latest News Clinical Trials Research Drugs Reports Corporate
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record